$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Fructus Corni Officinalis water extract Ameliorates Memory Impairment and Beta amyloid (Aβ) clearance by LRP-1 Expression in the Hippocampus of a Rat model of Alzheimer’s Disease 원문보기

동의생리병리학회지 = Journal of physiology & pathology in Korean Medicine, v.30 no.5, 2016년, pp.347 - 354  

Lee, Ju Won (Department of Korean Medical Science, Graduate School of East-West Medical Science, Kyung Hee University)

Abstract AI-Helper 아이콘AI-Helper

This study evaluated the effects of Fructus Corni Officinalis water extract (FCE) on congnitive impairment and Aβ clearance induced by beta amyloid Aβ (1-42) injection in the hippocampus of rat. Aβ (1-42) was injected into the hippocampus using a Hamilton syringe and micropump (5 ㎍/5 ㎕, 1 ㎕/min, eac...

주제어

AI 본문요약
AI-Helper 아이콘 AI-Helper

가설 설정

  • We confirmed Aβ clearance with LPR-1 immunostaining. We hypothesized that LRP-1 expression would decrease in the Aβ inj group, however our data demonstrated that change in LRP-1 expression varied by region. The AB inj group showed increased LRP-1 expression in CA1, but decreased expression in vessels.
본문요약 정보가 도움이 되었나요?

참고문헌 (37)

  1. Blennow, K., de Leon, M.J., Zetterberg, H. Alzheimer’s disease. Lancet 368(9533):387-403, 2006. 

  2. Dickson, D.W. The pathogenesis of senile plaques. J Neuropathol Exp Neurol 56(4):321-339, 1997. 

  3. Yates, S.L., Burgess, L.H., Kocsis-Angle, J., Antal, J.M., Dority, M.D., Embury, P.B., et al. Amyloid beta and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia. J Neurochem. 74(3):1017-1025, 2000. 

  4. Selkoe, D.J., Schenk, D. Alzheimer’s disease: Molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol. 43: 545-584, 2003. 

  5. Liu, H., Xing, A., Wang, X., Liu, G., Li, L. Regulation of β-amyloid level in the brain of rats with cerebrovascular hypoperfusion. Neurobiol Aging. 33(826):31-42, 2012. 

  6. Wang, Y.J., Zhou, H.D., Zhou, X.F. Clearance of amyloid-beta in Alzheimer's disease: progress, problemsand perspectives. Drug Discov Today. 11(20):931-938, 2006. 

  7. Donahue, J.E., Flaherty, S.L., Johanson, C.E., Duncan, J.A.3rd, Silverberg, G.D., Miller, M.C., Tavares, R., Yang, W., Wu, Q., Sabo, E., Hovanesian, V., Stopa, E.G. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease. Acta Neuropathol. 112(4):405-415, 2006. 

  8. Scripnikov, A., Khomenko, A., Napryeyenko, O. GINDEM-NP Study Group. Effects of Ginkgo biloba extract EGb 761 on neuropsychiatric symptoms of dementia: findings from a randomised controlled trial. Wien Med Wochenschr. 157(13):295-300, 2007. 

  9. Han, Y., Jung, H.W., Park, Y.K. Selective therapeutic effect of cornus officinalis fruits on the damage of different organs in STZ-induced diabetic rats. Am J Chin Med. 42(5):1169-1182, 2014. 

  10. Jeong, E.J., Kim, T.B., Yang, H., Kang, S.Y., Kim, S.Y., Sung, S.H., Kim, Y.C. Neuroprotective iridoid glycosides from Cornus officinalis fruits against glutamate-induced toxicity in HT22 hippocampal cells. Phytomedicine. 15(19):317-321, 2012. 

  11. Wang, W., Sun, F., An, Y., Ai, H., Zhang, L., Huang, W., Li, L. Morroniside protects human neuroblastoma SH-SY5Y cells against hydrogen peroxide-induced cytotoxicity. Eur J Pharmacol. 24(613):19-23, 2009. 

  12. Hong, S.Y., Jeong, W.S., Jun, M. Protective effects of the key compounds isolated from Corni fructus against β-amyloid-induced neurotoxicity in PC12 cells. Molecules. 10(17):10831-10845, 2012. 

  13. Blennow, K., de Leon, M.J., Zetterberg, H. Alzheimer's disease. Lancet. 29;368(9533):387-403, 2006. 

  14. Dickson, D.W. The pathogenesis of senile plaques. J Neuropathol Exp Neurol. 56(4):321-339. 1997. 

  15. Grundke-Iqbal, I., Iqbal, K., Quinlan, M., Tung, Y.C., Zaidi, M.S., Wisniewski, H.M. Microtubule-associated protein tau. A component of alzheimer paired helical filaments. J Biol Chem. 5;261(13):6084-6089, 1986. 

  16. Ball, M.J. Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. A quantitative study. Acta Neuropathol. 28;37(2):111-118, 1977. 

  17. Kuhl, D.E., Koeppe, R.A., Minoshima, S., Snyder, S.E., Ficaro, E.P., Foster, N.L., et al. In vivo mapping of cerebral acetylcholinesterase activity in aging and alzheimer's disease. Neurology. 10;52(4):691-699, 1999. 

  18. Selkoe, D.J. Amyloid beta-protein and the genetics of alzheimer's disease. J Biol Chem. 2;271(31):18295-19298, 1996. 

  19. Cacquevel, M., Lebeurrier, N., Cheenne, S., Vivien, D. Cytokines in neuroinflammation and alzheimer's disease. Curr Drug Targets. 5(6):529-534, 2004. 

  20. Berezovska, O., Lleo, A., Herl, L.D., Frosch, M.P., Stern, E.A., Bacskai, B.J., et al. Familial alzheimer's disease presenilin 1 mutations cause alterations in the conformation of presenilin and interactions with amyloid precursor protein. J Neurosci. 16;25(11):3009-3017, 2005. 

  21. Mhatre, M., Floyd, R.A., Hensley, K. Oxidative stress and neuroinflammation in alzheimer's disease and amyotrophic lateral sclerosis: Common links and potential therapeutic targets. J Alzheimers Dis. 6(2):147-157, 2004. 

  22. Roberson, M.R., Kolasa, K., Parsons, D.S., Harrell, L.E. Cholinergic denervation and sympathetic ingrowth result in persistent changes in hippocampal muscarinic receptors. Neuroscience. 80(2):413-418, 1997. 

  23. De Ferrari, G.V., Canales, M.A., Shin, I., Weiner, L.M., Silman, I., Inestrosa, N.C. A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation. Biochemistry. 4;40(35):10447-10457, 2001. 

  24. Deane, R., Bell, R., Sagare, A., Zlokovic, B. Clearance of amyloid-β peptide across the blood-brain barrier: Implication for therapies in Alzheimer’s disease. CNS & neurological disorders drug targets. 8(1):16-30, 2009. 

  25. Ramanathan, A., Nelson, A., Sagare, A., Zlokovic, B. Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer’s disease: The role, regulation and restoration of LRP1. Frontiers in Aging Neuroscience. 7: 136, 2015. 

  26. Bell, R.D., Sagare, A.P., Friedman, A.E., Bedi, G.S., Holtzman, D.M., Deane, R., et al. Transport pathways for clearance of human Alzheimer’s amyloid beta-peptideand apolipoproteins E and J in the mouse centralnervous system. J Cereb Blood Flow Metab. 27: 909-918, 2007. 

  27. Deane, R., Wu, Z., Sagare, A., Davis, J., Du Yan, S., Hamm, K., et al. LRP/amyloid beta-peptide interaction mediates differential brain efflux of Aβ isoforms. Neuron. 43: 333-344, 2004. 

  28. Lee, K.Y., Sung, S.H., Kim, S.H., Jang, Y.P., Oh, T.H., Kim, Y.C. Cognitive-enhancing activity of loganin isolated from Cornus officinalis in scopolamine-induced amnesic mice. Archives of Pharmacal Research. 32(5):677-683, 2009. 

  29. Wang, R., Zhang, Y., Li, J., Zhang, C. Resveratrol ameliorates spatial learning memory impairment induced by Aβ1-42 in rats. Neuroscience. S0306-4522(16)30433-X. 2016. 

  30. Ashabi, G., Alamdary, S.Z., Ramin, M., Khodagholi, F. Reduction of hippocampal apoptosis by intracerebroventricular administration of extracellular signal-regulated protein kinase and/or p38 inhibitors in amyloid beta rat model of Alzheimer's disease: involvement of nuclear-related factor-2 and nuclear factor-κB. Basic Clin Pharmacol Toxicol. 112(3):145-155, 2013. 

  31. Lecanu, L., Greeson, J., Papadopoulos, V. Beta-amyloid and oxidative stress jointly induce neuronal death, amyloid deposits, gliosis, and memory impairment in the rat brain. Pharmacology. 76: 19-33, 2006. 

  32. Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., Malinow, R. APP processing and synaptic function. Neuron. 37: 925-937, 2003. 

  33. Donahue, J.E., Flaherty, S.L., Johanson, C.E., Duncan, J.A.3rd, Silverberg, G.D., Miller, M.C., Tavares, R., Yang, W., Wu, Q., Sabo, E., Hovanesian, V., Stopa, E.G. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease. Acta Neuropathol. 112(4):405-415, 2006. 

  34. Shibata, M., Yamada, S., Kumar, S., Calero, M., Bading, J., Frangione, B., Holtzman, D., Miller, C., Strickland, D., Ghiso, J., Zlokovic, B. Clearance of Alzheimer’s amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 106: 1489-1499, 2000. 

  35. Tamaki, C., Ohtsuki, S., Iwatsubo, T., Hashimoto, T., Yamada, K., Yabuki, C. Major involvement of low-density lipoprotein receptor-related protein 1 in the clearance of plasma free amyloid beta-peptide by the liver. Pharm. Res. 23: 1407-1416, 2006. 

  36. Bell, R.D., Sagare, A.P., Friedman, A.E., Bedi, G.S., Holtzman, D.M., Deane, R. Transport pathways for clearance of human Alzheimer’s amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J. Cereb. Blood Flow Metab. 27: 909-918, 2007. 

  37. Sagare, A., Deane, R., Bell, R.D., Johnson, B., Hamm, K., Pendu, R. Clearance of amyloid-beta by circulating lipoprotein receptors. Nat. Med. 13: 1029-1031, 2007. 

관련 콘텐츠

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로